GB951767A - Improvements in or relating to pharmaceutical compositions and the preparation thereof - Google Patents
Improvements in or relating to pharmaceutical compositions and the preparation thereofInfo
- Publication number
- GB951767A GB951767A GB9499/60A GB949960A GB951767A GB 951767 A GB951767 A GB 951767A GB 9499/60 A GB9499/60 A GB 9499/60A GB 949960 A GB949960 A GB 949960A GB 951767 A GB951767 A GB 951767A
- Authority
- GB
- United Kingdom
- Prior art keywords
- specified
- dehydro
- phenylephrine
- suspensions
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
- C07D457/08—Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Pharmaceutical compositions comprise 1-dehydro-6-alpha-methylhydrocortisone, a 21-acylate thereof wherein the acyl group is that of an organic carboxylic acid containing from 1 to 12 carbon atoms inclusive, or a water-soluble salt of said acylates formed by polybasic carboxylic acids of 1 to 12 carbon atoms in which one carboxyl group is used in acylating the hydroxy group at the 21-position of the 1-dehydro-6-alpha-methyl analogue of hydrocortisone, a decongestant, and a pharmaceutically acceptable carrier. Specified decongestants are phenylephrine and its hydrochloride, theophylline or beta-(ortho-methoxy phenyl)-isopropyl methylamine hydrochloride. Specified water-soluble salts are the sodium, potassium, phenylephrine and N-methyl glucamine salts of the polybasic acid mono-esters. Specified pharmaceutical forms for enteral, parenteral and topical application are capsules, lozenges, pills, pilules, tablets, elixirs, solutions, syrups, sterile solutions and suspensions, dry sterile carriers, bougies, ointments, pastes, suppositories, inhalations, lotions, sprays and suspensions. Liquid topical forms may be pressurized. The compositions may contain disintegrators, lubricants, binders, flavours, sweetening agents, surfactants or preservatives, e.g. myristyl gamma-picolurium chloride. The composition may contain neomycin. Specification 853,981 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80169259A | 1959-03-25 | 1959-03-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB951767A true GB951767A (en) | 1964-03-11 |
Family
ID=25181809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9499/60A Expired GB951767A (en) | 1959-03-25 | 1960-03-17 | Improvements in or relating to pharmaceutical compositions and the preparation thereof |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE588797A (en) |
FR (1) | FR282M (en) |
GB (1) | GB951767A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1180364A1 (en) * | 2000-08-15 | 2002-02-20 | Octagene GmbH | Steroid hormones as transfer agents |
-
1960
- 1960-03-17 GB GB9499/60A patent/GB951767A/en not_active Expired
- 1960-03-18 BE BE588797A patent/BE588797A/en unknown
- 1960-08-25 FR FR836740A patent/FR282M/en active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1180364A1 (en) * | 2000-08-15 | 2002-02-20 | Octagene GmbH | Steroid hormones as transfer agents |
WO2002013791A2 (en) * | 2000-08-15 | 2002-02-21 | Octagene Gmbh | Steroid hormones as transfer agents |
WO2002013791A3 (en) * | 2000-08-15 | 2003-02-13 | Octagene Gmbh | Steroid hormones as transfer agents |
Also Published As
Publication number | Publication date |
---|---|
FR282M (en) | 1961-03-13 |
BE588797A (en) | 1960-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Du Vigneaud | The structure of biotin | |
ATE1374T1 (en) | DEVICE FOR TRANSFERRING SIGNS TO OBJECTS. | |
GB951767A (en) | Improvements in or relating to pharmaceutical compositions and the preparation thereof | |
GB8620917D0 (en) | Platinum derivatives & cancer treatments | |
DE3563971D1 (en) | 1-alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them | |
ES2065343T3 (en) | NEW PHARMACEUTICAL PREPARATIONS AS WELL AS NEW LACTOSIL COMPOUNDS AND THEIR PREPARATION. | |
AU566233B2 (en) | Flowable oxytetracycline hydrochloride | |
EP0301474A3 (en) | New cysteine derivatives having expectorant activity | |
GB971243A (en) | Substituted 4-phenylaminoquinolines | |
Ishihara et al. | Studies on actinoleukin, relation to echinomycin and levomycin | |
GB972672A (en) | Pharmaceutical preparations containing compounds of the androstane series | |
JPS5434773A (en) | Vacuum tweezers | |
FR2305976B1 (en) | ||
JPS5247283A (en) | Apparatus for detaching hook of a hanger for supporting shaft-like art icles | |
GB794483A (en) | Steroid compounds and process | |
TH2666A (en) | Modification of Cefarosporin Derivatives or Related Substances | |
JPS55157595A (en) | Weak basic nitrogen-containing compound amylostatin y | |
KR840005730A (en) | Method for preparing a compound having analgesic and anti-inflammatory action | |
TH2666EX (en) | Modification of cefarosporin derivatives or related substances | |
FR1271406A (en) | Process for preparing a cuprous phthalocyanine pigment mainly in alpha form and stable to recrystallization | |
GB917575A (en) | Pharmaceutical anti-inflammatory compositions containing glycyrrhetinic acid isomers | |
GB912594A (en) | Apparatus for forming tabs for marking articles | |
JPS5237375A (en) | Device for aranging moving intervals of articles to be carried | |
AU160675B2 (en) | Improvements in or relating to a process for the production of hexamethylene - 1:6 - bis-trimethylammonium bitartrate and pharmaceutical preparations containing same | |
GB908634A (en) | Pharmaceutical compositions containing pararosaniline or derivatives thereof |